LBRX
NASDAQ · Pharmaceuticals
Lb Pharmaceuticals Inc
$30.92
+0.32 (+1.05%)
Open$30.36
Previous Close$30.60
Day High$31.21
Day Low$30.05
52W High$33.47
52W Low$13.36
Volume—
Avg Volume230.2K
Market Cap860.30M
P/E Ratio—
EPS$-1.72
SectorPharmaceuticals
Analyst Ratings
Strong Buy
12 analysts
Price Target
-50.8% upside
Current
$30.92
$30.92
Target
$15.21
$15.21
$11.61
$15.21 avg
$18.52
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 167.53M | 154.99M | 171.21M |
| Net Income | 47.95M | 36.94M | 41.17M |
| Profit Margin | 28.6% | 23.8% | 24.1% |
| EBITDA | 61.52M | 61.45M | 59.09M |
| Free Cash Flow | 46.38M | 48.44M | 62.84M |
| Rev Growth | -8.2% | -9.0% | +5.4% |
| Debt/Equity | 1.06 | 1.00 | 0.91 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,117.26 | +0.92% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $241.00 | +0.80% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $120.60 | +0.84% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.04 | -2.75% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.17 | +1.73% | 12.5 | 33.00B |